Evaluation of depressive disorders in patients with ankylosing spondylitis
DOI:
https://doi.org/10.11603/1811-2471.2016.v25.i1.6007Abstract
SUMMARY. It was found that people with first diagnose of ankylosing spondylitis have the highest level of depressive
disorders. Subsequent adequate treatment can achieve significant improvement in emotional state for 1–10 years of
illness. However, with the gradual progression of the disease, irreversible changes in conditions significantly worsen the
quality of life, which manifested with significant deterioration in the psycho-emotional sphere and in need of medical
correction.
Key words : ankylosing spondylitis, depression.
References
http://www.who.int/mediacentre/factsheets/en/
Nakaz Ministerstva okhorony zdorovʺya Ukrayiny
vid 25 hrudnya 2014 r. № 1003.
Depression increasesthe risk of hypertension incidence:
a meta-analysis of prospective cohort studies /
L. Meng, D. Chen, Y. Yang [et al.] // J. Hypertens. – 2012. –
№ 30 (5). – R. 842–851.
Coronaryendothelialdysfunctionassociated with a
depressive mood in patients with atypicalangina but angiographically
normal coronary artery / J. H. Kim, J. W . Kim,
Y. H. Ko [et al.] // Int. J. Cardiol. – 2010. – № 143 (2). –
R. 154–157.
Yusuf S., Hawken S., Ounpu S., et al. on behalf of
the INTERHEART Study Investigators. Effect of potentially
modifiable risk factors associated with myocardial infarction
in 52 countries (the INTERHEART Study): case-control
study.www.thelancet.com. / S. Yusuf, S. Hawken, S. Ounpu,
[et al.] Published online September 2004; 3.
Platelet functionin patients with major depression
/ R. C. Ziegelstein, K. Parakh, A. Sakhuja, U. Bhat // Int.
Med. J. – 2008. – № 39 (1). – R. 38–43.
Depression.An underestimated risk for the development
and progressionof coronary heart disease /
K. H. Ladwig, R. T. Emeny, S. Hafner, M. E. Lacruz // Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz.
– 2011. – № 54 (1). – R. 59–65.
Ford D. I. Depression and Creactive protein in US
adults) Third National Health and Nutrition Examination
Survey / D. I. Ford, T. P. Erlinger // Arch. Intern. Med. –
– № 164 (9). – 1010 r.
Plante G. E. Depression and cardiovascular disease:
a reciprocalrelationship / G. E. Plante // Metabolism. –
№ 54 (5 Suppl. 1). – R. 45–48.
Endothelial biomarkers in depressed patients
treated with the selective serotonin reuptake inhibitor sertraline
after acute coronary events: the Sertraline AntiDepressant
Heart Attack Randomized Trial (SADHART) Platelet
Substudu / V. L. Serebryan, A. H. Glassman, A. I. Malinin
[et al.] // Circulation. – 2003. – № 108 (8). – R. 939–944.
Chronic diseasesand risk for depression in old
age: a meta-analysis of publishedliterature / C. Q. Huang,
B. R. Dong, Z. C. Lu [et al.] // Ageing. Res. Rev. – 2010. –
№ 9 (2). – R. 131–141.
Impact of depression syndrome in the management
of cardiovascularrisk factors in primary prevention:
State of the art / M. Colotto, G. Rubini, C. Savoriti [et al.] //
Clin. Ter. – 2010. – № 161 (3). – R. 105–110.
Depression and the risk for cardiovascular diseases:
systematic review and meta analysis / Van K. der Kooy,
H. van Hout, H. Marwijk [et al.] // Int. J. Geriatr. Psychiatry.
– 2007. – № 22 (7). – R. 613–626.
Voinov B. Depression and chronicdiseases: it is
time for a synergistic mental health and primarycare approach
/ B. Voinov, W. D. Richie, R. K. Bailey // Prim. Care
Companion CNS Disord. – 2013. – Vol. 15 (2).
URL: http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3733529/(available: 28.05.2014).
Korsakova N. K., Ékspress-metodyka otsenky
kohnytyvnykh funktsyy pry normalʹnom starenyy /
N. K. Korsakova, E. YU. Balashova, Y. F. Roshchyna // Zhur-
nal nevrolohyya y psykhyatryya. – 2009. – № 2. – R. 44–50.
